Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chlordiazepoxide,Clidinium
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Dr Reddy's Labs Receives US FDA Approval for Generic Librax
Details : The Librax brand and generic market had US sales of approximately $105.9 million MAT for the most recent twelve months ending in July 2021 according to IQVIA Health.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 31, 2021
Lead Product(s) : Chlordiazepoxide,Clidinium
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?